Competition and Markets Authority cases and projects

From:: Competition and Markets Authority

This case finder includes cases and projects from the Competition and Markets Authority (CMA), Office for the Internal Market (OIM) and Subsidy Advice Unit (SAU).

Hydrocortisone tablets: alleged excessive and unfair pricing, anti-competitive agreements and abusive conduct (50277)
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
Investigation into suspected anti-competitive conduct by Vifor Pharma in relation to intravenous iron treatments
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 31 January 2024
Liothyronine tablets: suspected excessive and unfair pricing
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 25 October 2016
Phenytoin sodium capsules: suspected unfair pricing
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Outcome type: CA98 - infringement Chapter II
- Opened: 1 May 2013
Pharmaceuticals: anti-competitive agreements
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 10 October 2017
Pharmaceutical drugs: suspected anti-competitive agreements
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Opened: 10 October 2017
Paroxetine investigation: anti-competitive agreements and conduct
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 11 August 2011
Nortriptyline investigation: anti-competitive agreement and conduct
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - infringement Chapter I
- Opened: 10 October 2017
Investigation into supply of lithium-based medication for the treatment of bipolar disease
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - commitments
- Opened: 5 October 2020
- Closed: 18 December 2020
Fludrocortisone acetate tablets: anti-competitive agreement (50455)
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - infringement Chapter I
- Opened: 10 October 2017
Pharmaceutical sector: suspected anti-competitive agreements and conduct 50780
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - administrative priorities
- Opened: 10 October 2017
- Closed: 25 November 2019
Hydrocortisone tablets: alleged anti-competitive agreements and abusive conduct (50277-3)
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 18 October 2017
Hydrocortisone tablets: alleged anti-competitive agreements and abusive conduct (50277-2)
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 12 April 2016
Hydrocortisone tablets: alleged excessive and unfair pricing (50277-1)
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 8 March 2016
Remicade: alleged abusive discount scheme
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - no grounds for action
- Opened: 1 December 2015
Pharmaceutical sector: suspected anti-competitive agreements
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Opened: 10 October 2017
- Closed: 14 November 2018
Conduct in the pharmaceutical sector investigation
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - administrative priorities
- Opened: 24 June 2014
- Closed: 4 June 2015
Reckitt Benckiser: alleged abuse of a dominant position
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - infringement Chapter II
- Opened: 1 November 2008
- Closed: 13 April 2011
Procter & Gamble Pharmaceuticals UK: alleged abuse of a dominant position
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - no grounds for action
- Opened: 1 October 2005
- Closed: 1 May 2008
Genzyme Ltd: alleged abuse of a dominant position
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - infringement Chapter II
- Opened: 1 March 2000
- Closed: 27 March 2003
Napp Pharmaceutical Holdings Ltd: alleged abuse of a dominant position
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - infringement Chapter II
- Opened: 1 March 2000
- Closed: 15 January 2002

21 cases

Case type

Case state

Market sector

Outcome

Opened

Closed

21 cases

Is this page useful?

Help us improve GOV.UK

Help us improve GOV.UK

Cookies on GOV.UK

Competition and Markets Authority cases and projects

Filter

21 cases

Case type

Case state

Market sector

Outcome

Opened

Closed

21 cases

Is this page useful?

Help us improve GOV.UK

Help us improve GOV.UK